Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuganlin Oral Liquid in Children With Influenza
NCT02622659Phase 4Completed
- Sponsor
- ApicHope Pharmaceutical Group
- Start
- Mar 2012
- Primary completion
- Mar 2014
- Modality
- Biologic, Traditional Chinese Medicine Formula
- Countries
- 1
01
Overview
A Phase 4 trial of Fuganlin Oral Liquid in acute upper respiratory infection (URI), influenza, sponsored by ApicHope Pharmaceutical Group. Started Mar 2012; status: completed.
02
Drugs
Fuganlin Oral Liquid
03
Conditions
acute upper respiratory infection (URI)influenza
Beyond the preview
Go deeper on NCT02622659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02622659.